Vi använder cookies och analysverktyg (Google Analytics, Google Tag Manager) för att förbättra din upplevelse. Genom att acceptera samtycker du till användningen av dessa tekniker. Du kan ändra dina inställningar när som helst.

blog.fallback_notice_title
blog.fallback_notice_body
blog.key_takeaways
Searches for exosomes vs polynucleotides reflect a shift in aesthetic medicine. Patients are no longer asking only how to fill or freeze. They are asking how to improve tissue quality, healing behavior, and longer-term skin resilience.
In my 30+ years of clinical experience in Istanbul, regenerative treatments create the best value when they are chosen for a specific biological reason. Trend language alone is not enough. The skin needs a defined problem before it needs a premium solution.
Exosome-based protocols are often discussed for signaling support, post-laser recovery, broader regenerative messaging, and adjunctive tissue repair strategies. Polynucleotides are more often framed around tissue quality, hydration support, repair environment, and collagen-friendly recovery.
The overlap is real, but the planning logic is different. One protocol may be better when the emphasis is recovery signaling, while the other may fit calmer long-term tissue support more elegantly.
I look at skin fragility, downtime tolerance, inflammation tendency, recent laser or microneedling plans, and whether the patient needs a repair-support strategy or a slower tissue-quality protocol. Budget also matters because regenerative plans can become expensive very quickly.
This decision should be read alongside the exosome skin rejuvenation guide and the collagen preservation article because regenerative treatments only make sense inside a wider tissue plan.
Dr. Gemici: Regenerative medicine is useful when it becomes more precise, not when it becomes more fashionable.
Neither treatment should be sold as an overnight age reversal tool. The usual goal is improved skin behavior over time: calmer recovery, better hydration quality, better surface resilience, and support for collagen-oriented treatment plans.
If the patient actually needs diagnosis around skin age and broader prevention, I would prioritize biological skin age reversal protocols before choosing a premium regenerative add-on.
This article is a support piece inside the decision cluster. Together with Juvederm vs Restylane and Botox vs face lift, it helps patients compare treatment categories rather than collect generic aesthetic content.
Not universally. The better choice depends on the treatment goal, recovery context, skin behavior, and how the protocol fits the full plan.
Usually no. They are often supportive tools inside a broader rejuvenation strategy rather than full replacements for every other category.
No. Some patients get more value from simpler prevention, skincare discipline, or conventional treatments chosen well.

Trusted & Professional
Dr. Hamza Gemici is a medical aesthetic physician based in Ataşehir, Istanbul. His practice focuses on natural anti-aging and subtle facial harmonization using botulinum toxin, dermal fillers, periocular rejuvenation and skin quality procedures. All treatments are performed with FDA-approved products under physician-guided protocols.